Labshake search
Citations for Stemcell Technologies :
301 - 350 of 785 citations for 5 Bromo 2 Tert Butyldimethylsilyl 4 Methylthiazole since 2020
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
A scalable, GMP-compatible, autologous organotypic cell therapy for Dystrophic Epidermolysis BullosabioRxiv - Bioengineering 2023Quote: ... 2% BSA (Miltenyi) and 10 uM ROCK inhibitor (StemCell technologies 72302). For all wash steps ...
-
bioRxiv - Neuroscience 2023Quote: ... Each plate was then split 1:2 using ReLeSR (StemCell Technologies), with half of the cells used for DNA extraction for Sanger sequencing ...
-
bioRxiv - Neuroscience 2024Quote: ... supplemented with 2% Neurocult SM1 Neuronal Supplement (StemCell Technologies; cat. #05711), 1% horse serum (Atlanta Biologicals ...
-
bioRxiv - Neuroscience 2024Quote: ... coated plates with 1.5-2 ml of mTeSR1 media (STEMCELL Technologies), media were changed daily except the day after passing ...
-
bioRxiv - Immunology 2024Quote: ... and 50 IU/mL of IL-2 (STEMCELL Technologies, cat. 78220) at 1 million cells/mL ...
-
bioRxiv - Microbiology 2024Quote: ... then grown in presence of 100U/mL IL-2 (StemCell Technologies) for 4 days before being used in the various experiments ...
-
bioRxiv - Cell Biology 2024Quote: ... supplemented with or without 10 µM IWP-2 (STEMCELL Technologies, #72122) and 5% Matrigel matrix ...
-
bioRxiv - Cancer Biology 2024Quote: ... supplemented with 300IU/ml recombinant human IL-2 (Stemcell Technologies, 78036) for 14 days ...
-
bioRxiv - Physiology 2020Quote: ... Undifferentiated hiPSCs were maintained on Vitronectin XF (5 μg/mL, Stem Cell Technologies) coated tissue culture dishes as per manufacturer recommendation with either mTeSR medium with supplementation or mTeSR PLUS medium with supplementation (Stem Cell Technologies) ...
-
bioRxiv - Developmental Biology 2021Quote: ... 300 U/mL of hyaluronidase and 5 mg/mL DNAse I (StemCell Technologies) under gentile agitation for 10 min ...
-
bioRxiv - Developmental Biology 2021Quote: ... 300 U/mL of hyaluronidase and 5 mg/mL DNAse I (StemCell Technologies) under gentile agitation for 10 min ...
-
bioRxiv - Neuroscience 2024Quote: ... and passaged every 3-5 days using ReLeSR™ (#05872; Stem Cell Technology).
-
bioRxiv - Cancer Biology 2023Quote: ... supplemented with 5% FBS and 1:10 dilution of collagenase/hyaluronidase (STEMCELL Technologies) at 37°C for 3 hr ...
-
bioRxiv - Cancer Biology 2023Quote: ... pelleted cells were resuspended with pre-warmed 5 mg/ml dispase (STEMCELL Technologies) supplemented with 1:10 dilution of 1 mg/ml DNase I (STEMCELL Technologies) ...
-
bioRxiv - Molecular Biology 2023Quote: ... supplemented with a final concentration of 5 μM XAV-939 (STEMCELL Technologies, #72672) on 1:100 geltrex (GIBCO ...
-
bioRxiv - Developmental Biology 2024Quote: ... it was switched to PXGL medium (N2B27 medium supplemented with 1 μM PD0325901, 2 μM XAV939 [STEMCELL Technologies, 72674], 2 μM Gö6983 [STEMCELL Technologies, 72462], and 10 ng/mL LIF), refreshed daily for an additional 8-10 days before passaging ...
-
bioRxiv - Neuroscience 2020Quote: ... Cells were passaged every 4 to 7 days with ReLeSR reagent (StemCell Technologies catalog #05872) to ensure that only undifferentiated stem cells remained in the cultures ...
-
bioRxiv - Genomics 2021Quote: ... and 4) one cord blood (CB001) collected with informed consent by StemCell Technologies (catalog #70007) (Table S1) ...
-
bioRxiv - Cell Biology 2024Quote: ... The cells were passaged every 3-4 days by dissociating them using Accutase (STEMCELL Technologies) according to manufacturer’s protocol ...
-
bioRxiv - Cancer Biology 2023Quote: Primary cells are resuspended in a 3:4 solution of Mammocult medium (Stem Cell Technology) and Matrigel (Corning)17,26,29 ...
-
bioRxiv - Bioengineering 2023Quote: ... Cells were passaged every 4 days by non-enzymatic dissociation with ReLeSR (StemCell Technologies Inc.) and plated at a density of 5.0×105 per 60 mm plate.
-
bioRxiv - Bioengineering 2023Quote: ... and passaged every 3-4 days using Gentle Cell Dissociation Reagent (STEMCELL Technologies, 100-0485) for clump passaging ...
-
bioRxiv - Cancer Biology 2024Quote: 200-500 edited residual HSCs were added to 4 mL of MethoCult H4435 (Stemcell Technologies) and differentiated for 14 days ...
-
bioRxiv - Genetics 2024Quote: ... every other day and passaged every 3–4 days with Accutase (Stem Cell Technologies 07920) or ReLeSR (Stem Cell Technologies 100-0483) ...
-
bioRxiv - Molecular Biology 2021Quote: ... 2 million cells were passaged per each well using Accutase (StemCell Technologies) into the STEMdiff SMADi neural induction medium (StemCell Technologies) ...
-
bioRxiv - Bioengineering 2021Quote: ... supplemented with 10 ng μL-1 recombinant human IL-2 (StemCell Technologies) and activated with the ImmunoCult Human CD3/CD28 T Cell Activator (StemCell Technologies) ...
-
bioRxiv - Cancer Biology 2021Quote: ... 20 ng/ml basic-FGF and 2 μg/ml Heparin (StemCell Technologies). L0125 and L0512 GBM tumorspheres were kindly provided by Dr ...
-
A critical role for heme synthesis and succinate in the regulation of pluripotent states transitionsbioRxiv - Developmental Biology 2022Quote: ... Cells were passaged every 2-3 days using accutase (Stemcell Technologies, #07920). Cells were then collected by centrifugation at 1200 rpm for 3 minutes and counted before seeding ...
-
bioRxiv - Cancer Biology 2021Quote: ... 20 ng/ml basic-FGF and 2 μg/ml Heparin (StemCell Technologies). S24 Tdtomato/GFP cells were kindly gifted by Dr ...
-
bioRxiv - Neuroscience 2022Quote: ... Heparin solution 2 μg/ml (cat# 07980, Stem Cell Technologies, Vancouver, Canada), EGF 20 ng/ml (Cat#315-09 ...
-
bioRxiv - Neuroscience 2024Quote: ... Cells were passaged 1-2 times per week with ReLeSR (STEMCELL Technologies) when they reached 80-90% confluence ...
-
bioRxiv - Cancer Biology 2023Quote: ... and fed IL-2 (50 U/mL; Stem Cell Technologies, Vancouver, Canada) every 48 hours ...
-
bioRxiv - Molecular Biology 2023Quote: ... HUDEP 2 cells were cultured in Stemspan Media (SFEM II - STEMCELL Technologies) with 50ng/ml SCF (ImmunoTools) ...
-
bioRxiv - Neuroscience 2024Quote: ... and routinely split 1-2 times a week with ReLeSR (STEMCELL Technologies) without ROCKi (Y-27632 ...
-
bioRxiv - Genomics 2024Quote: ... cells were resuspended with 1-2 mL Dispase (Stem Cell Technologies, 07923) and 200 µL 1mg/mL DNase I (Stem Cell Technologies ...
-
Most L1CAM is not associated with extracellular vesicles in human biofluids and iPSC–derived neuronsbioRxiv - Neuroscience 2024Quote: ... using STEMdiff™ APEL™2 serum-free differentiation medium (StemCell Technologies) supplemented with bFGF (10 ng/ml ...
-
bioRxiv - Bioengineering 2024Quote: ... Wells were coated with 2 mL of anti-adhesion solution (Stemcell Technologies) for 30 minutes according to the manufacturer’s protocol ...
-
bioRxiv - Cell Biology 2024Quote: ... and supplemented with Heparin solution 2 μg/mL (#07980, Stem Cell Technologies), EGF 20 ng/mL ...
-
bioRxiv - Cancer Biology 2020Quote: ... unfractionated nucleated BM cells (5×105) were suspended in methylcellulose medium (M3231, StemCell Technologies) with 0.1 ...
-
bioRxiv - Cancer Biology 2020Quote: ... unfractionated nucleated BM cells (5×105) were suspended in methylcellulose medium (M3231, StemCell Technologies) with 0.01 ng/ml murine GM-CSF (Peprotech ...
-
bioRxiv - Biochemistry 2022Quote: ... Cells were passaged every 5-7 days using ReLeSR (STEMCELL Technologies, Vancouver, BC, Canada) and maintained within passages 20 to 50.
-
bioRxiv - Bioengineering 2021Quote: ... coiled-coil containing protein kinase (ROCK) inhibitor (5 μM, StemCell Technologies, Vancouver, BC, Canada). Until 95% confluency was reached ...
-
bioRxiv - Cancer Biology 2022Quote: ... at a density of 5×103 cells/ml in Complete MammoCult Medium (StemCell Technologies). After seven days ...
-
bioRxiv - Neuroscience 2023Quote: ... iPSCs were passaged every 5-6 days using ReLeSR dissociation reagent (STEMCELL Technologies, 05872) and used for hematopoietic stem cell differentiation with STEMdiff Hematopoietic kit (STEMCELL Technologies ...
-
bioRxiv - Molecular Biology 2022Quote: ... at 37°C and passaged every 5-6 days using ReLeSR (Stem Cell Technologies).
-
bioRxiv - Developmental Biology 2024Quote: ... iPSCs lines were passaged every 5 days using Gentle Cell Dissociation Reagent (Stemcell Technologies) and plated in mTesr1 in the presence of 10 uM Y-27632 (Stemcell Technologies) ...
-
bioRxiv - Genetics 2024Quote: ... Cells were differentiated for 5 days with the STEMDiff hepatocyte kit (Stem Cell Technologies), according to the manufacturer’s instructions ...
-
bioRxiv - Cell Biology 2024Quote: ... followed by 48 hours of 5 µM IWR-1-endo (Stem Cell Technologies 72562) on day 4 ...
-
bioRxiv - Pharmacology and Toxicology 2024Quote: ... Cell passaging was done every 5-6 days with ReLeSR™ (Stem Cell Technologies) according to the manufacturer’s instructions ...
-
bioRxiv - Cell Biology 2024Quote: ... cells were manually dissociated by pipetting with dispase (5 U, Stem Cell Technologies, 07913) and DNase (100 μg ...